<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: <z:hpo ids='HP_0000819'>Diabetes mellitus</z:hpo> has been historically divided into type 1 and type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, with type 1 being an <z:hpo ids='HP_0002960'>autoimmune disease</z:hpo> and type 2 being primarily a <z:e sem="disease" ids="C0025517" disease_type="Disease or Syndrome" abbrv="">metabolic disease</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>CONTENT: The current <z:mp ids='MP_0002055'>diabetes</z:mp> classification scheme needs to be reevaluated because of the accumulating evidence of immune system involvement in the pathophysiology of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>SUMMARY: There are similarities and differences between type 1 and type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> with regard to pathogenesis, pathophysiology, and genetics </plain></SENT>
<SENT sid="3" pm="."><plain>We propose a resolution to the dilemma of the current classification scheme </plain></SENT>
</text></document>